r.rotation.to⌕ Search stocks, people, sectors
Request a free account

Follow the people · Insider

MH

Michael Thomas Henderson

Insider · Chief Executive Officer · APGE

Michael Thomas Henderson files insider transactions with the SEC as a chief executive officer of Apogee Therapeutics (APGE). We hold 10 disclosed purchases and sales filed since 3 July 2019, 4 of them in the last 90 days.

  • Files forAPGE
  • Disclosed buys and sells10 in all, 4 in the last 90 days
  • Last disclosure3 September 2026

Positions held

4 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 18 December 2023 — 3 September 2026Chief Executive Officer · Apogee Therapeutics (APGE)75 Form 4 lines · source: SEC Form 4
  • Filed 14 May 2024 — 22 June 2026Director · Spyre Therapeutics (SYRE)11 Form 4 lines · source: SEC Form 4
  • Filed 31 July 2024 — 31 July 2024Director · ARYA Sciences Acquisition Corp IV (ARYD)1 Form 4 line · source: SEC Form 4
  • Filed 1 July 2019 — 15 December 2020Chief Business Officer · BridgeBio Pharma (BBIO)87 Form 4 lines · source: SEC Form 4

Everything they disclosed

120 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.